| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3419151 | Revista Iberoamericana de Micología | 2009 | 4 Pages |
Abstract
The clinical results, its safety profile and the low grade of medical interactions permit micafungin to be considered for therapy in specific groups of transplant patients.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Jesús Fortún-Abete,